Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions. The reviews were commissioned by the World Health Organization (WHO) to inform ...
Oct 29, 2025
0
28
How men lose weight could affect their chances of having a baby, with new research from the University of Adelaide revealing healthy lifestyle behaviors seem more beneficial for improving fertility than weight loss itself.
Oct 28, 2025
0
25
The basic principle of weight loss is straightforward: if you consume fewer calories than you burn, you'll lose weight. In practice though, this isn't usually so easy or simple.
Oct 20, 2025
0
28
There's mounting evidence that popular drugs prescribed for diabetes management and weight loss—better known by trade names like Ozempic and Wegovy—could be effective in reducing alcohol use.
Oct 15, 2025
0
41
A new method of taking microscopic images of a live mouse's retina through the eye allows researchers to record the reaction of brain cells to disease and treatment. The Kobe University development is more easily applicable ...
Oct 6, 2025
0
66
Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s.
Sep 18, 2025
0
26
Maintaining weight loss with regular exercise rather than the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide, a drug used to treat type 2 diabetes and obesity, seems to reduce atherosclerosis development in ...
Sep 16, 2025
0
19
For older adults with type 2 diabetes, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with nonarteritic anterior ischemic optic neuropathy (NAION), according to a research letter published online July ...
Aug 5, 2025
0
15
A new study published by Cleveland Clinic researchers in Diabetes, Obesity and Metabolism investigating the genetic underpinnings of weight loss response has identified a gene, neurobeachin (NBEA), as a predictor of how individuals ...
Jul 21, 2025
0
30
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight, food intake and many measures of appetite more than placebo and liraglutide. These results ...
Jul 9, 2025
0
34
